UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease

Neuroscience, 2010-02, Vol.165 (3), p.662-674

2010

Volltextzugriff (PDF)

ALPHA-SYNUCLEIN DEFICIENCY IN THE C57BL/6JOIaHsd STRAIN DOES NOT MODIFY DISEASE PROGRESSION IN THE ME7-MODEL OF PRION DISEASE

Neuroscience, 2010-02, Vol.165 (3), p.662-674

2010

Volltextzugriff (PDF)

Degenerating Synaptic Boutons in Prion Disease: Microglia Activation without Synaptic Stripping

The American journal of pathology, 2009-10, Vol.175 (4), p.1610-1621

2009

Volltextzugriff (PDF)

Fibronectin impedes “myelin” sheet-directed flow in oligodendrocytes: A role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking

Molecular and cellular neuroscience, 2006-10, Vol.33 (2), p.150-159

2006

Volltextzugriff (PDF)

Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity

Molecular and cellular neuroscience, 2009-10, Vol.42 (3), p.234-242

2009

Volltextzugriff (PDF)

CRF and urocortin differentially modulate GluR delta 2 expression and distribution in parallel fiber-Purkinje cell synapses

Molecular and cellular neuroscience, 2005-12, Vol.30 (4), p.513-522

2005

Volltextzugriff (PDF)

Preliminary study on the monitoring of glutathione S-tranferase activity toward styrene oxide by electromigration methods

Journal of separation science, 2005-08, Vol.28 (12), p.1357-1362

2005

Volltextzugriff (PDF)

P22 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: THE DEL(5Q) SIZE IN MDS IS CORRELATED TO KARYOTYPE COMPLEXITY AND FREQUENCY OF TP53 MUTATIONS

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations

Leukemia research, 2021-09, Vol.108, p.106681, Article 106681.22

2021

Volltextzugriff (PDF)

High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients

Leukemia research, 2017-04, Vol.55, p.S132-S132

2017

Volltextzugriff (PDF)

Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

Leukemia research, 2017-04, Vol.55, p.S115-S115

2017

Volltextzugriff (PDF)

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)

Leukemia research, 2017-04, Vol.55, p.S56-S57

2017

Volltextzugriff (PDF)

MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels

Leukemia research, 2017-04, Vol.55, p.S132-S132

2017

Volltextzugriff (PDF)

170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS?

Leukemia research, 2015-04, Vol.39, p.S86-S87

2015

Volltextzugriff (PDF)

191 - Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

Leukemia research, 2017-04, Vol.55, p.S115-S115

2017

Volltextzugriff (PDF)

Betaine increases the butyrylcholinesterase activity in rat plasma

Physiological research, 2016-01, Vol.65 (1), p.101-108

2016

Volltextzugriff (PDF)

227 - High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients

Leukemia research, 2017-04, Vol.55, p.S132-S132

2017

Volltextzugriff (PDF)

228 - MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels

Leukemia research, 2017-04, Vol.55, p.S132-S132

2017

Volltextzugriff (PDF)

90 - Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)

Leukemia research, 2017-04, Vol.55, p.S56-S57

2017

Volltextzugriff (PDF)

PS1330 VARIABILITY IN THE EXTENT OF DEL(5Q) AND ITS CLINICAL IMPLICATION IN MYELODYSPLASTIC SYNDROMES (MDS)

HemaSphere, 2019-06, Vol.3 (S1), p.607-n/a

2019

Volltextzugriff (PDF)

301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)

Leukemia research, 2011, Vol.35, p.S119-S119

2011

Volltextzugriff (PDF)

264 Genomic imbalances in 73 patients with MDS and complex karyotypes

Leukemia research, 2011, Vol.35, p.S104-S104

2011

Volltextzugriff (PDF)

274 The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatment

Leukemia research, 2011, Vol.35, p.S108-S108

2011

Volltextzugriff (PDF)

Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14152-e14152

2011

Volltextzugriff (PDF)

250 Are Fli1, EKLF, PU.1, HDM2 and TP53 factors implicated in refractory anemia and megakaryopoiesis in 5q- syndrome?

Leukemia research, 2011, Vol.35, p.S98-S98

2011

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(10)
Science & Technology
(10)
Life Sciences & Biomedicine
(8)
Humans
(7)
Male
(7)
Animals
(6)
Female
(6)
Adult
(4)
Biological And Medical Sciences
(4)
Middle Aged
(4)
Neurosciences
(4)
Neurosciences & Neurology
(4)
Rats
(4)
Medical Sciences
(3)
Rats, Wistar
(3)
Adolescent
(2)
Aged
(2)
Chemistry
(2)
Disease Progression
(2)
Ecm
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease

ALPHA-SYNUCLEIN DEFICIENCY IN THE C57BL/6JOIaHsd STRAIN DOES NOT MODIFY DISEASE PROGRESSION IN THE ME7-MODEL OF PRION DISEASE

Degenerating Synaptic Boutons in Prion Disease: Microglia Activation without Synaptic Stripping

Fibronectin impedes “myelin” sheet-directed flow in oligodendrocytes: A role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking

Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity

CRF and urocortin differentially modulate GluR delta 2 expression and distribution in parallel fiber-Purkinje cell synapses

Preliminary study on the monitoring of glutathione S-tranferase activity toward styrene oxide by electromigration methods

P22 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: THE DEL(5Q) SIZE IN MDS IS CORRELATED TO KARYOTYPE COMPLEXITY AND FREQUENCY OF TP53 MUTATIONS

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations

High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients

Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)

MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels

170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS?

191 - Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

Betaine increases the butyrylcholinesterase activity in rat plasma

227 - High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients

228 - MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels

90 - Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)

PS1330 VARIABILITY IN THE EXTENT OF DEL(5Q) AND ITS CLINICAL IMPLICATION IN MYELODYSPLASTIC SYNDROMES (MDS)

301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)

264 Genomic imbalances in 73 patients with MDS and complex karyotypes

274 The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatment

Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience

250 Are Fli1, EKLF, PU.1, HDM2 and TP53 factors implicated in refractory anemia and megakaryopoiesis in 5q- syndrome?

Suchergebnisse filtern